Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Sep 25;14(2):309–316. doi: 10.1016/j.cgh.2015.09.015

Sex and Ethnic Differences in the Association of Obesity with Risk of Hepatocellular Carcinoma

Veronica Wendy Setiawan 1,2, Unhee Lim 3, Loren Lipworth 4, Shelly C Lu 5, John Shepherd 6, Thomas Ernst 7, Lynne R Wilkens 3, Brian E Henderson 1,2, Loïc Le Marchand 3
PMCID: PMC4718778  NIHMSID: NIHMS725117  PMID: 26404865

Abstract

Background & Aims

Obesity is associated with increased risk for hepatocellular carcinoma (HCC), but the risk associated with obesity may vary by sex or ethnicity. We examined whether the association of body mass index (BMI) with HCC incidence, as well as correlations of BMI with total, visceral, and hepatic adiposity, differs among ethnic groups.

Methods

We collected data from the Multiethnic Cohort Study, a population-based prospective cohort study of more than 215,000 men and women from Hawaii and California, assembled from 1993 through 1996. After a median follow up of 16.6 years, 482 incident HCC cases were identified among 168,476 participants. BMI and risk factor data were obtained from a baseline questionnaire. Cox regression analyses were used to calculate hazard ratios (HRs) and confidence intervals (CIs) for HCC associated with BMI. The African Americans in the Southern Community Cohort Study (SCCS) were included as a replication cohort.

Results

BMI was associated with HCC in men (HR per 5 kg/m2 increase=1.26; 95% CI, 1.12–1.42) but not in women (HR=1.06; 95% CI, 0.90–1.25) (Pinteraction=.009). Although BMI was strongly associated with HCC in Japanese, white, and Latino men, there was no association in African-American men (Pinteraction=.002). Similarly, no association was found in the African-American who participated in the SCCS. BMI correlated with total fat mass, measured by dual-energy X-ray absorptiometry, in men and women and in all ethnic groups (R≥0.9). However, there was a lower correlation value for BMI and visceral or liver fat measured by abdominal MRI in African-American men (R<0.5) and in women (R<0.8).

Conclusions

Based on an analysis of data from the Multiethnic Cohort Study, the association between BMI and HCC differs between sexes and among ethnicities. The lack of association in African-American men warrants further investigation. Rather than studying markers of total adiposity, studies of obesity and HCC should move beyond BMI and use a better measure for fat-specific depots.

Keywords: Liver Cancer, MEC study, epidemiology, visceral adiposity


The incidence of hepatocellular carcinoma (HCC) in the United States (US) has tripled during the past three decades1. The health impact of the increasing incidence of HCC is compounded by its poor prognosis, since its overall 5-year survival is <12%2. Among all major cancers in the US, HCC has shown the greatest annual percent increase in mortality rate between 1975 and 20103. In 2013, HCC was the 7th most common cause of cancer mortality in the US, accounting for more than 21,000 deaths3.

While all ethnic groups have shown an increase in HCC incidence, marked differences in rates have been reported by race/ethnicity4. Asians/Pacific Islanders and Hispanics have the highest incidence rates, at 3-fold and 2-fold higher than the rates among non-Hispanic whites, respectively5. The rates for Hispanics are rising the fastest among all racial/ethnic groups5, 6.

The obesity epidemic, in part through development of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD), is thought to have contributed to these increasing HCC trends7, 8. Obesity as measured by BMI has been associated with HCC risk4. However, a previous study suggested that obesity was positively associated with HCC in whites, but not in African Americans9.

Previous studies suggest that there are substantial ethnic differences in body fat distribution1012. Compared to whites with similar total adiposity, Latinos and Asians are more likely, and African Americans less likely, to accumulate fat in the abdominal visceral compartment and in the liver1315. We hypothesized that if such ethnic differences in the obesity-HCC association are confirmed, they may be explained by variation in body fat distribution. Indeed, visceral adiposity has been suggested to be more important for predicting HCC risk than total adiposity1618.

The purpose of this study was to examine the association of BMI with HCC incidence as well as the correlations of BMI with total, visceral and hepatic adiposity in five ethnic groups from the Multiethnic Cohort (MEC) Study.

Materials and Methods

Study Population

The details of the MEC and baseline characteristics have been published19. Briefly, the MEC is a population-based prospective cohort study of over 215,000 men and women from Hawaii and California (mainly Los Angeles County), assembled between 1993 and 1996. Potential participants, aged 45 to 75 years at recruitment, were identified primarily through Department of Motor Vehicles drivers’ list, voter registration lists, and Health Care Financing Administration data files. All participants returned a self-administered 26-page questionnaire that obtained information on demographic, anthropometric measures, and lifestyle factors including diet.

For the current study, we excluded participants not from the five major ethnic groups (N=13,988), participants with cancer diagnosis except non-melanoma skin cancer prior to cohort entry as reported on the baseline questionnaire or as identified by linkage to the tumor registries (N=19,385), participants with implausible dietary energy and macronutrient intakes (N=8,257), and participants with missing data on baseline weight, height, diabetes, smoking status, alcohol intake, and education (N=5,461). A total of 168,476 participants were available for analysis.

Case Ascertainment

Incident HCC cases [International Classification of Diseases for Oncology version 3 topographic (C22.0) and morphology codes (8170–8175)] were identified through annual linkage to the Hawaii Tumor Registry, the Cancer Surveillance Program for Los Angeles County and the California State Cancer Registry, which are part of the NCI’s Surveillance, Epidemiology and End Results (SEER) program. Case ascertainment was complete through December 31, 2010. After a median duration of follow up of 16.6 years, a total of 482 incident HCC cases were identified. Linkages to the National Death Index and death certificate files in Hawaii and California provided information on vital status.

Assessment of BMI and other risk factors

On the baseline questionnaire, participants were asked to self-report their current weight and height. BMI was calculated as weight in kg divided by height in m2. Data on demographic factors and other risk factors including alcohol intake, smoking status, and physician-diagnosed type 2 diabetes were also obtained from the baseline questionnaire20. Waist and hip measurements were not collected at baseline.

MEC adiposity data

For the BMI-fat depot correlation analysis, specifically for visceral and hepatic adiposity, we utilized data from a subset of 256 MEC participants who were re-contacted to undergo detailed adiposity measurements (whole-body DXA, abdominal MRI, and anthropometry) for a separate project. Subjects who were 60–72 years of age in January 2013 and living in Oahu or Los Angeles county were recruited using stratified sampling to obtain a balanced representation of each sex and ethnic group in each of six BMI categories (18.5–22, 22>-25, 25>-27.5, 27.5>-30, 30>-35, >35 kg/m2), following a previously tested protocol21, 22. After accounting for the sampling scheme which allowed a comparison of regional fat depots across ethnicities at various levels of total adiposity, the samples were generally representative of the entire cohort. The Institutional Review Boards at the University of Hawaii (UH) and the University of Southern California (USC) approved the study, and all participants signed an informed consent. Total and regional body fat mass in the trunk, arms and legs was measured using Hologic Discovery/A DXA systems (Hologic, Inc., Bedford, MA) at UH and USC. Visceral and subcutaneous fat and hepatic fat were estimated from abdominal MRI scans performed with a 3-Tesla system [Siemens TIM Trio scanner (Siemens Medical Solutions USA, Inc., Malvern, PA) at UH, GE HDx (GE Healthcare, Madison, WI) at USC]. Visceral and subcutaneous fat area (cm2) was measured in a series of water-suppressed lipid scans at each of the L1–L5 intervertebral positions, and liver fat (% volume) was estimated in axial triple gradient-echo scans of the lateral portion of the right lobe21.

Southern Community Cohort Study (SCCS)

The SCCS is a prospective cohort study, focused on cancer disparities related to race, of black and white adults enrolled primarily from community health centers in the southeastern US between 2002 and 200923, 24. Given the small number of HCC cases among African Americans in the MEC, we additionally included African-American participants from the SCCS in order to enhance our ability to examine the BMI-HCC association specifically in this population group for which a previous study did not show an association9. For this study, we utilized a nested case-control study of incident HCC and four controls matched to each case by age (± 2 years), race, menopausal status (women) and enrollment location. We included 83 African-American cases and 332 controls in our analysis. The number of HCC cases was small in whites (N=18) and they were excluded from our analysis. Similar to the MEC, BMI was calculated based on self-reported weight and height at baseline questionnaire; smoking status, diabetes, and alcohol intake were also assessed at baseline.

Statistical Analysis

BMI was categorized as <25, 25-<30, and ≥30 kg/m2. The association between BMI and HCC in the MEC was assessed by hazard ratios (HRs) and 95% confidence intervals (CIs) from Cox proportional hazards regression while adjusting for known risk factors and potential confounders. Age (in days) was used as the underlying time variable in the Cox regression starting with a participant’s age at entry (baseline questionnaire completion) and ending with the earliest of these endpoints: date of HCC diagnosis, date of death, or end of follow up (December 31, 2010). Adjustment variables in the Cox model included ethnicity (as a stratum variable), sex (as a stratum variable), age at cohort entry (continuous), education (high school or less, some college, college graduate or higher), history of diabetes (yes, no), cigarette smoking status (never, past, current), and alcohol intake (never, <24 g/day, ≥24 g/day ethanol). The proportional hazards assumption was tested by assessing the Schoenfeld residuals and no major violation was observed. The BMI-HCC association in the SCCS was assessed by odds ratios (ORs) and 95% CI from conditional logistic regression stratified by matching set and adjusted for smoking status, diabetes, and alcohol intake. Tests for trend were performed by entering the ordinal values (i.e., 1,2,3) representing categories of BMI as continuous variables in the models. Test of heterogeneity for risks between sex or ethnic groups was assessed using the Wald test for the cross-product terms between BMI trend variable and sex or ethnicity. For the BMI-fat depot correlation analysis, the age-adjusted partial correlation of BMI with total, visceral and liver fat was computed. All analyses were done using SAS 9.2 (SAS Institute, Cary, NC). All P values were two-sided.

Results

Baseline characteristics of the study population by sex and race/ethnicity are shown in Table 1. Japanese and African Americans represented the oldest groups and Native Hawaiians the youngest group. Whites and Japanese had the highest level of education (college graduate or more), while the majority of Latinos had completed high school or less. There was a five-fold difference in the prevalence of obesity (BMI ≥30 kg/m2) across the five ethnic groups. With the exception of Japanese (8% in men and 6% in women), obesity was more frequent in all of the non-white groups (~25% in Latinos and African American men, 29% in Latinas, ~35% in Native Hawaiians, and 38% in African-American women) than in whites (17% in men, 18% in women). The prevalence of diabetes was highest in Latinos, followed by African Americans, Native Hawaiians, Japanese, and whites. Current smoking was most common among African-American men (27%), while heavy alcohol drinking was most common among white men (27%).

Table 1.

Characteristics of the study population by sex and race/ethnicity

Characteristics Male Female

White African American Nat. Hawaiian Japanese American Latino White African American Nat. Hawaiian Japanese American Latino
No. of at risk 19,341 10,178 5,588 23,830 19,137 21,620 17,620 6,771 25,154 19,237
No. of HCC cases 47 52 28 100 112 9 26 6 57 45
Age at cohort entry (years) mean (SD) 58.3 (8.9) 61.0 (8.9) 56.4 (8.4) 60.7 (9.2) 59.9 (7.7) 58.4 (8.9) 60.3 (9.0) 55.8 (8.6) 60.5 (9.0) 59.1 (7.7)
Education, %
 High school or less 22.0 40.8 50.0 36.4 64.3 29.5 39.7 54.8 41.3 72.1
 Some college 29.2 36.7 30.8 30.3 23.6 33.4 37.6 28.8 29.4 19.6
 College graduate or more 48.8 22.5 19.2 33.3 12.1 37.1 22.7 16.4 29.3 8.4
BMI (kg/m2), %
 <25 37.4 29.5 19.6 49.8 24.9 53.3 25.1 31.7 69.4 31.6
 25-<30 45.6 47.8 43.7 42.4 53.6 28.4 37.1 33.1 24.2 39.8
 ≥ 30 16.9 22.7 36.7 7.9 21.5 18.3 37.8 35.2 6.4 28.6
Diabetes, % 6.0 15.8 15.8 11.9 16.4 5.2 14.9 13.3 8.8 14.6
Smoking status, %
 Never 32.3 24.5 31.8 29.3 31.7 45.3 45.7 45.1 68.9 65.0
 Past 51.1 48.1 46.3 55.4 50.0 38.1 34.3 31.4 21.9 24.4
 Current 16.6 27.4 21.9 15.3 18.3 16.6 19.9 23.5 9.2 10.5
Alcohol intake, %
 None 28.0 43.4 41.5 44.7 35.5 40.3 62.6 62.7 77.2 64.3
 <24 ethanol g/day 45.0 40.5 39.6 39.3 48.4 47.7 32.6 32.7 21.2 33.4
 ≥ 24 ethanol g/day 27.0 16.1 18.9 16.0 16.0 12.0 4.8 4.6 1.6 2.3

Table 2 shows the associations between BMI and HCC incidence by sex. Increasing BMI conferred a greater risk of HCC in men than in women (P interaction =0.036). Men who were overweight (BMI 25-<30 kg/m2) and obese (BMI ≥30 kg/m2) had a 1.5- and 1.8-fold increased HCC risk compared with those of normal weight, respectively (P for trend= 0.0002). For a change of 5 kg/m2 in BMI levels, men had a 26% increase in risk of HCC, which was significantly greater than the 6% non-significant increase in risk in women (P interaction=0.009).

Table 2.

Association of BMI with hepatocellular carcinoma incidence by sex

Male Female

No. Cases HR1 (95% CI) No. Cases HR1 (95% CI) P interaction2
BMI (kg/m2)
 <25 90 1.00 62 1.00
 25-<30 173 1.50 (1.16, 1.95) 43 0.98 (0.65, 1.48) 0.036
 ≥30 76 1.82 (1.31, 2.52) 38 1.32 (0.83, 2.11)
P trend 0.0002 0.29
Per 5 kg/m2 increase 339 1.26 (1.12, 1.42) 143 1.06 (0.90, 1.25) 0.009
1

Adjusted for age at cohort entry, race/ethnicity, education, alcohol intake, smoking status, and diabetes.

2

Interaction between sex and BMI was tested by the Wald test with 1 degree of freedom.

Because of the limited number of female cases and non-significant BMI-HCC association in women, the ethnic-specific results are presented only in men (Table 3). The association of BMI with HCC differed significantly across ethnic groups (P interaction=0.003). Having a BMI ≥30 kg/m2 was associated with HCC risk in Japanese (HR=3.43; 95% CI: 1.76, 6.69), Latinos (HR=2.18; 95% CI: 1.21, 3.93), whites (HR=1.82; 95% CI: 0.82, 4.03), and Native Hawaiians (HR=1.41; 95% CI: 0.47, 4.19), but not in African Americans (HR =0.61; 95% CI: 0.27, 1.36). Japanese, Latinos, whites, and Native Hawaiians had an increased risk of 77%, 34%, 20% and 17% per change of 5 kg/m2 in BMI, respectively. No corresponding significant association was seen in African Americans (HR=0.78; 95% CI: 0.55, 1.11). We also found that BMI was not associated with HCC in African-American men (54 cases; OR =0.86; 95% CI: 0.63, 1.19) in the SCCS. Using a fixed-effect meta-analysis model, the combined association for African Americans across the two cohorts was 0.82 (95% CI: 0.65, 1.04; P heterogeneity=0.69).

Table 3.

Association of BMI with hepatocellular carcinoma incidence in men by race/ethnicity

White African American Native Hawaiian Japanese American Latino
Multiethnic Cohort Study

No. Cases HR* (95% CI) No. Cases HR* (95% CI) No. Cases HR* (95% CI) No. Cases HR* (95% CI) No. Cases HR* (95% CI) P interaction2
BMI (kg/m2)
 <25 13 1.00 21 1.00 6 1.00 32 1.00 18 1.00
 25-<30 21 1.22 (0.61, 2.46) 22 0.67 (0.37, 1.23) 13 1.25 (0.47, 3.32) 55 2.23 (1.44, 3.47) 62 1.66 (0.98, 2.82) 0.003
 ≥30 13 1.82 (0.82, 4.03) 9 0.61 (0.27, 1.36) 9 1.41 (0.47, 4.19) 13 3.43 (1.76, 6.69) 32 2.18 (1.21, 3.93)
P trend 0.15 0.17 0.54 <0.0001 0.009
Per 5 kg/m2 increase 47 1.20 (0.87, 1.66) 52 0.78 (0.55, 1.11) 28 1.17 (0.83, 1.65) 100 1.77 (1.42, 2.19) 112 1.34 (1.09, 1.63) 0.002

Southern Community Cohort Study
BMI (kg/m2) No. Cases OR** (95% CI)
 <25 20 1.00
 25-<30 25 1.46 (0.70, 3.06)
 ≥30 9 0.88 (0.35, 2.21)
P trend 0.95
Per 5 kg/m2 increase 54 0.86 (0.63, 1.19)
*

HR adjusted for age at cohort entry, education, smoking status, diabetes, and alcohol intake.

**

OR stratified by matching set and adjusted for smoking status, diabetes and alcohol intake.

2

Interaction between race/ethnicity and BMI was tested by the Wald test with 4 degrees of freedom.

Table 4 shows the correlations between BMI and fat distribution by sex and by ethnicity in the subset of 256 participants. In general, in men, BMI was equally and quite strongly correlated with total and visceral fat but more weakly with liver fat. In contrast to the other groups, in African-American men, the correlation with BMI was weaker for both visceral and liver fat. In women, BMI was highly correlated with total fat but less so with visceral fat and even less so with liver fat, this in a more similar manner across ethnic groups than for men.

Table 4.

Correlation of BMI with total, visceral and liver adiposity by sex and race/ethnicity

All White African American Native Hawaiian Japanese American Latino
Men N=127 N=27 N=21 N=27 N=29 N=23
 Age (Mean, SD) 68.4 (2.5) 68.5 (2.3) 68.1 (2.1) 68.3 (3.1) 68.2 (2.2) 68.8 (2.6)
 BMI (Mean, SD) 27.9 (4.8) 27.6 (5.1) 28.2 (4.1) 28.7 (5.0) 27.8 (4.6) 27.2 (4.9)
Correlation Coefficienta
 Total fat (kg) 0.89* 0.94* 0.89* 0.87* 0.89* 0.90*
 Visceral fat at L3L4 (cm2) 0.81* 0.91* 0.50 0.73* 0.87* 0.91*
 Liver fat (% volume) 0.55* 0.69* 0.35 0.71* 0.65 0.61
Women N=129 N=24 N=27 N=26 N=27 N=25
 Age (Mean, SD) 68.4 (2.9) 68.4 (2.4) 69.4 (2.5) 67.0 (3.6) 68.7 (2.4) 68.5 (2.8)
 BMI (Mean, SD) 27.7 (5.3) 27.3 (5.7) 28.7 (6.0) 28.0 (5.2) 27.2 (4.3) 27.3 (5.4)
Correlation Coefficienta
 Total fat (kg) 0.88* 0.91* 0.89* 0.92* 0.87* 0.95*
 Visceral fat at L3L4 (cm2) 0.69* 0.83* 0.74* 0.79* 0.64 0.52
 Liver fat (% volume) 0.41* 0.58 0.45 0.50 0.43 0.37
a

adjusted for age at examination;

*

P<0.0001

Discussion

In this large prospective study, we observed significant sex- and ethnic-differences in the association between BMI and HCC risk. We found BMI to be significantly associated with HCC risk only in men. Furthermore, whereas BMI was strongly associated with HCC risk in Japanese-American, white and Latino men, it was not associated with HCC risk in African-American men. We also showed that BMI correlated well with total fat mass measured by total body DXA in men and women and in all ethnic groups. However, the correlations of BMI with visceral or liver fat measured by abdominal MRI were weaker in African-American men and in women.

Previous meta-analyses showed that risk of HCC associated with increasing BMI levels was either stronger in men than in women25, 26 or only seen in men27. Our results are consistent with these previous data. It is known that men have more visceral fat compared to women2830. It has also been suggested that visceral adiposity maybe more important for predicting HCC risk than total adiposity1618. Visceral adipose tissue is thought to modulate a range of systemic and end-organ effects through the release of adipocytokines, growth factors and inflammatory markers, and it has been associated with hyperinsulinemia, NAFLD, and severity of liver inflammation and fibrosis in non-alcoholic steatohepatitis (NASH)18, 31. Two studies to date have investigated the association between body fat distribution and HCC 32, 33. The first study from the EPIC cohort showed that across all anthropometric indices (BMI, height, waist circumference, waist-to-hip ratio, etc.), waist-to-height ratio, a surrogate for abdominal obesity, had the strongest association with HCC risk32. In a multivariable analysis, adjusting for other anthropometric measures, BMI was no longer associated with HCC, while the association with waist-to-height ratio remained32. The second study found that computed tomography-determined visceral fat was an independent risk factor for HCC recurrence in Japanese patients with suspected NASH33. The stronger BMI-HCC association observed in men could be explained by the sexual dimorphism in visceral fat accumulation and/or with the weaker correlations between BMI and visceral and liver fat in women.

To our knowledge, only one study has examined whether the association of obesity and HCC differs by race9, and this study included mainly white and African-American men, with no Asian Americans and limited Hispanic Americans. This US veteran study found that the ICD-9-identified obesity (ICD-9=278.0) was associated with HCC in opposite directions for African-American men (RR=0.68; 95% CI: 0.49, 0.94) and white men (RR=1.44; 95% CI: 1.28, 1.61; P<0.001). In both the MEC and SCCS, we observed no association between BMI and HCC risk among African-American men which could be explained by a lower amount of visceral fat30, 34, lower correlations between BMI and visceral and liver fat, and/or other factors that may attenuate the risk of HCC among obese persons in this population.

As discussed by El-Serag and Kanwal35, BMI is a rather gross and likely distal operator in explaining the link between obesity and HCC. BMI does not distinguish more metabolically active visceral fat or liver fat from other body fat30 and it does not distinguish fat from lean mass36. To add to the complexity, our results show that the correlations of BMI with the size of specific fat depots differ by sex and ethnic group.

The strengths of this study include its ethnic diversity, prospective design, long follow up, large sample size and detailed information on most HCC risk factors. Another strength is that in the BMI-adiposity correlation analysis, we used the gold standard measurements of body fat to allow for a more precise and valid comparison of body fat distribution across ethnic/groups. There are also several study limitations. Our analysis is based on exposure collected at baseline based on self-report, and thus exposure misclassification, as well as changes in exposures during follow up, cannot be ruled out. Even in our relatively large cohort, the number of cases within categories of BMI by sex and ethnic group were small. The limited number of female cases might reduce our ability to observe substantial excess risk in any or many of the specific subgroups in contrast to what was observed in males. Hepatitis B (HBV) and C viral infection (HCV) status were not available for the entire study population; thus, they could not be adjusted for in the analyses. In the nested case-control study of HCC within the MEC with HBV and HCV serologic data20, 37 infection status was not associated with BMI and the interaction between BMI and viral hepatitis on HCC risk was not statistically significant. However, a recent study showed an interaction between BMI and viral hepatitis on HCC risk38; thus, we cannot exclude potential confounding or effect modification by viral hepatitis in our study.

In conclusion, the association of BMI with risk of HCC varies by sex and ethnic groups. The lack of association in African-American men is particularly interesting and warrants further investigation. Rather than studying total adiposity, studies of obesity and HCC should move beyond BMI and use better and more specific markers for fat-specific depots.

Acknowledgments

Grant Support: National Cancer Institute grants CA164973, CA168530, and CA186203.

We thank the MEC participants for their participations and commitment.

Abbreviations

BMI

body mass index

CI

confidence interval

DXA

dual-energy X-ray absorptiometry

HCC

hepatocellular carcinoma

HR

hazard ratios

MEC

Multiethnic Cohort Study

MRI

magnetic resonance imaging

NAFLD

non-alcoholic fatty liver disease

SCCS

Southern Community Cohort Study

Footnotes

Conflict of interest: the authors have nothing to disclose.

Author contributions: study concept and design (VWS, JS, TC, BEH, LLM); acquisition of data (UL, BEH, LLM); analysis and interpretation (VWS, UL, LL, LRW, LLM); drafting of the manuscript (VWS, UL, LL, SCL, LRW, BEH, SCL, LLM); critical revision of the manuscript for important intellectual content (VWS, UL, LL, SCL, LRW, BEH, LLM) ; statistical analysis (VWS, LRW); obtained funding (VWS, BEH, LLM).

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(9):1485–91. doi: 10.1200/JCO.2008.20.7753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mittal S, El-Serag HB. Epidemiology of Hepatocellular Carcinoma: Consider the Population. Journal of clinical gastroenterology. 2013 doi: 10.1097/MCG.0b013e3182872f29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2010. National Cancer Institute; Bethesda, MD: Apr, 2013. http://seercancergov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site. [Google Scholar]
  • 4.McGlynn KA, London WT. The global epidemiology of hepatocellular carcinoma: present and future. Clinics in liver disease. 2011;15(2):223–43. vii–x. doi: 10.1016/j.cld.2011.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.El-Serag HB, Kanwal F. Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go? Hepatology. 2014 doi: 10.1002/hep.27222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.El-Serag HB, Lau M, Eschbach K, et al. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Archives of internal medicine. 2007;167(18):1983–9. doi: 10.1001/archinte.167.18.1983. [DOI] [PubMed] [Google Scholar]
  • 7.Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma. Gastroenterology. 2004;127(5 Suppl 1):S97–103. doi: 10.1053/j.gastro.2004.09.021. [DOI] [PubMed] [Google Scholar]
  • 8.Vanni E, Bugianesi E. Obesity and liver cancer. Clinics in liver disease. 2014;18(1):191–203. doi: 10.1016/j.cld.2013.09.001. [DOI] [PubMed] [Google Scholar]
  • 9.Samanic C, Gridley G, Chow WH, et al. Obesity and cancer risk among white and black United States veterans. Cancer causes & control : CCC. 2004;15(1):35–43. doi: 10.1023/B:CACO.0000016573.79453.ba. [DOI] [PubMed] [Google Scholar]
  • 10.Araneta MR, Barrett-Connor E. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obesity research. 2005;13(8):1458–65. doi: 10.1038/oby.2005.176. [DOI] [PubMed] [Google Scholar]
  • 11.Lear SA, Humphries KH, Kohli S, et al. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT) The American journal of clinical nutrition. 2007;86(2):353–9. doi: 10.1093/ajcn/86.2.353. [DOI] [PubMed] [Google Scholar]
  • 12.Azuma K, Kadowaki T, Cetinel C, et al. Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States. Metabolism: clinical and experimental. 2009;58(8):1200–7. doi: 10.1016/j.metabol.2009.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Wagenknecht LE, Scherzinger AL, Stamm ER, et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) 2009;17(6):1240–6. doi: 10.1038/oby.2009.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Guerrero R, Vega GL, Grundy SM, et al. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology. 2009;49(3):791–801. doi: 10.1002/hep.22726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387–95. doi: 10.1002/hep.20466. [DOI] [PubMed] [Google Scholar]
  • 16.Ohki T, Tateishi R, Sato T, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2008;6(4):459–64. doi: 10.1016/j.cgh.2008.02.012. [DOI] [PubMed] [Google Scholar]
  • 17.Zhao J, Lawless MW. Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer. Cytokine. 2013;64(3):626–37. doi: 10.1016/j.cyto.2013.09.009. [DOI] [PubMed] [Google Scholar]
  • 18.Vongsuvanh R, George J, Qiao L, et al. Visceral adiposity in gastrointestinal and hepatic carcinogenesis. Cancer letters. 2013;330(1):1–10. doi: 10.1016/j.canlet.2012.11.038. [DOI] [PubMed] [Google Scholar]
  • 19.Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. American journal of epidemiology. 2000;151(4):346–57. doi: 10.1093/oxfordjournals.aje.a010213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Setiawan VW, Hernandez BY, Lu SC, et al. Diabetes and racial/ethnic differences in hepatocellular carcinoma risk: the multiethnic cohort. Journal of the National Cancer Institute. 2014;106(12) doi: 10.1093/jnci/dju326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lim U, Ernst T, Buchthal SD, et al. Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutrition & diabetes. 2011;1:e6. doi: 10.1038/nutd.2011.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lim U, Turner SD, Franke AA, et al. Predicting total, abdominal, visceral and hepatic adiposity with circulating biomarkers in Caucasian and Japanese American women. PloS one. 2012;7(8):e43502. doi: 10.1371/journal.pone.0043502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Signorello LB, Hargreaves MK, Blot WJ. The Southern Community Cohort Study: investigating health disparities. Journal of health care for the poor and underserved. 2010;21(1 Suppl):26–37. doi: 10.1353/hpu.0.0245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Signorello LB, Hargreaves MK, Steinwandel MD, et al. Southern community cohort study: establishing a cohort to investigate health disparities. Journal of the National Medical Association. 2005;97(7):972–9. [PMC free article] [PubMed] [Google Scholar]
  • 25.Chen Y, Wang X, Wang J, et al. Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies. Eur J Cancer. 2012;48(14):2137–45. doi: 10.1016/j.ejca.2012.02.063. [DOI] [PubMed] [Google Scholar]
  • 26.Saunders D, Seidel D, Allison M, et al. Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Alimentary pharmacology & therapeutics. 2010;31(10):1051–63. doi: 10.1111/j.1365-2036.2010.04271.x. [DOI] [PubMed] [Google Scholar]
  • 27.Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569–78. doi: 10.1016/S0140-6736(08)60269-X. [DOI] [PubMed] [Google Scholar]
  • 28.Nedungadi TP, Clegg DJ. Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. Journal of cardiovascular translational research. 2009;2(3):321–7. doi: 10.1007/s12265-009-9101-1. [DOI] [PubMed] [Google Scholar]
  • 29.Mongraw-Chaffin ML, Anderson CA, Allison MA, et al. Association between sex hormones and adiposity: qualitative differences in women and men in the multi-ethnic study of atherosclerosis. The Journal of clinical endocrinology and metabolism. 2015;100(4):E596–600. doi: 10.1210/jc.2014-2934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Carroll JF, Chiapa AL, Rodriquez M, et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity (Silver Spring) 2008;16(3):600–7. doi: 10.1038/oby.2007.92. [DOI] [PubMed] [Google Scholar]
  • 31.van der Poorten D, Milner KL, Hui J, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449–57. doi: 10.1002/hep.22350. [DOI] [PubMed] [Google Scholar]
  • 32.Schlesinger S, Aleksandrova K, Pischon T, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. International journal of cancer. 2013;132(3):645–57. doi: 10.1002/ijc.27645. [DOI] [PubMed] [Google Scholar]
  • 33.Ohki T, Tateishi R, Shiina S, et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut. 2009;58(6):839–44. doi: 10.1136/gut.2008.164053. [DOI] [PubMed] [Google Scholar]
  • 34.Camhi SM, Bray GA, Bouchard C, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 2011;19(2):402–8. doi: 10.1038/oby.2010.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.El-Serag HB, Kanwal F. Obesity and hepatocellular carcinoma: hype and reality. Hepatology. 2014;60(3):779–81. doi: 10.1002/hep.27172. [DOI] [PubMed] [Google Scholar]
  • 36.Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes (Lond) 2010;34(5):791–9. doi: 10.1038/ijo.2010.5. [DOI] [PubMed] [Google Scholar]
  • 37.Setiawan VW, Wilkens LR, Lu SC, et al. Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology. 2015;148(1):118–25. doi: 10.1053/j.gastro.2014.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hassan MM, Abdel-Wahab R, Kaseb A, et al. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015;149(1):119–29. doi: 10.1053/j.gastro.2015.03.044. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES